These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20671927)

  • 1. Cytokines and growth factors stimulate hyaluronan production: role of hyaluronan in epithelial to mesenchymal-like transition in non-small cell lung cancer.
    Chow G; Tauler J; Mulshine JL
    J Biomed Biotechnol; 2010; 2010():485468. PubMed ID: 20671927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
    Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
    Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
    Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM
    Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
    Kitamura K; Seike M; Okano T; Matsuda K; Miyanaga A; Mizutani H; Noro R; Minegishi Y; Kubota K; Gemma A
    Mol Cancer Ther; 2014 Feb; 13(2):444-53. PubMed ID: 24258346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line.
    Rho JK; Choi YJ; Lee JK; Ryoo BY; Na II; Yang SH; Kim CH; Lee JC
    Lung Cancer; 2009 Feb; 63(2):219-26. PubMed ID: 18599154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer.
    Bae GY; Choi SJ; Lee JS; Jo J; Lee J; Kim J; Cha HJ
    Oncotarget; 2013 Dec; 4(12):2512-22. PubMed ID: 24318272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction.
    Meran S; Luo DD; Simpson R; Martin J; Wells A; Steadman R; Phillips AO
    J Biol Chem; 2011 May; 286(20):17618-30. PubMed ID: 21454519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.
    Thomson S; Petti F; Sujka-Kwok I; Epstein D; Haley JD
    Clin Exp Metastasis; 2008; 25(8):843-54. PubMed ID: 18696232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.
    Twarock S; Freudenberger T; Poscher E; Dai G; Jannasch K; Dullin C; Alves F; Prenzel K; Knoefel WT; Stoecklein NH; Savani RC; Homey B; Fischer JW
    Mol Cancer; 2011 Mar; 10():30. PubMed ID: 21429221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
    Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
    Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging fibroblasts resist phenotypic maturation because of impaired hyaluronan-dependent CD44/epidermal growth factor receptor signaling.
    Simpson RM; Wells A; Thomas D; Stephens P; Steadman R; Phillips A
    Am J Pathol; 2010 Mar; 176(3):1215-28. PubMed ID: 20093489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I.
    Liu X
    Cell Motil Cytoskeleton; 2008 Dec; 65(12):935-44. PubMed ID: 18792103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 beta and transforming growth factor-beta 3 cooperate to activate matrix metalloproteinase expression and invasiveness in A549 lung adenocarcinoma cells.
    Petrella BL; Armstrong DA; Vincenti MP
    Cancer Lett; 2012 Dec; 325(2):220-6. PubMed ID: 22796605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salinomycin suppresses TGF-β1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer.
    Hwang KE; Kim HJ; Song IS; Park C; Jung JW; Park DS; Oh SH; Kim YS; Kim HR
    Int J Med Sci; 2021; 18(3):715-726. PubMed ID: 33437206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of 14-3-3γ Suppresses Epithelial-Mesenchymal Transition and Reduces Metastatic Potential of Human Non-small Cell Lung Cancer Cells.
    Raungrut P; Wongkotsila A; Champoochana N; Lirdprapamongkol K; Svasti J; Thongsuksai P
    Anticancer Res; 2018 Jun; 38(6):3507-3514. PubMed ID: 29848704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
    Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
    BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
    Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
    Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulatory role of APE1 in epithelial-to-mesenchymal transition and in determining EGFR-TKI responsiveness in non-small-cell lung cancer.
    Yang X; Peng Y; Jiang X; Lu X; Duan W; Zhang S; Dai N; Shan J; Feng Y; Li X; Cheng Y; Yang Y; Baugh L; Tell G; Wang D; Li M
    Cancer Med; 2018 Sep; 7(9):4406-4419. PubMed ID: 30109782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.